0

Journal Articles

in Thromboembolism/Anticoagulation
 121-140 of 766 Articles
JAMA Neurology | 
Correspondence |  November 01, 2010
Possible Influence of Stroke Etiology on Hemorrhagic Transformation Following Thrombolysis in Warfarin-Treated Patients
Dar Dowlatshahi, MD, PhD; Martin O’Donnell, MB, PhD; Mukul Sharma, MD, MSc
Arch Neurol. 2010;67(11):1413. doi:10.1001/archneurol.2010.286.
JAMA Neurology | 
Correspondence |  November 01, 2010
Worse Outcomes and Guideline-Driven Care
Giuseppe Famularo, MD, PhD; Fulvio Forino, MD; Laura Gasbarrone, MD
Arch Neurol. 2010;67(11):1413-1414. doi:10.1001/archneurol.2010.287.
JAMA Neurology | 
Correspondence |  November 01, 2010
Worse Outcomes and Guideline-Driven Care—Reply
Shyam Prabhakaran, MD, MS; Ji Y. Chong, MD
Arch Neurol. 2010;67(11):1413-1414. doi:10.1001/archneurol.2010.288.
JAMA Neurology | 
Original Contribution |  November 01, 2010 FREE
Very Early Neurologic Improvement After Intravenous Thrombolysis
Ioan-Paul Muresan, MD; Pascal Favrole, MD; Pierre Levy, MD; et al.
Arch Neurol. 2010;67(11):1323-1328. doi:10.1001/archneurol.2010.265.
INCLUDES: CME
JAMA Internal Medicine | 
Review Article |  October 25, 2010 FREE
Risk of Recurrence After a First Episode of Symptomatic Venous Thromboembolism Provoked by a Transient Risk Factor:  A Systematic Review
Alfonso Iorio, MD; Clive Kearon, MD; Esmeralda Filippucci, MD; et al.
Arch Intern Med. 2010;170(19):1710-1716. doi:10.1001/archinternmed.2010.367.
INCLUDES: CME
JAMA Internal Medicine | 
Research Letters |  October 25, 2010 FREE
Prevalence of Venous Thromboembolism Among Privately Insured US Adults
Sheree L. Boulet, DrPH; Scott D. Grosse, PhD; W. Craig Hooper, PhD; et al.
Arch Intern Med. 2010;170(19):1774-1775. doi:10.1001/archinternmed.2010.336.
JAMA Surgery | 
Special Feature |  October 01, 2010 FREE
Image of the Month—Quiz Case
Satoshi Ogiso, MD; Gen Nishikawa, MD; Hiroaki Hata, MD; et al.
Arch Surg. 2010;145(10):1017. doi:10.1001/archsurg.2010.221-a.
JAMA | 
Original Contribution |  September 22, 2010 FREE
Low-Dose vs Standard-Dose Unfractionated Heparin for Percutaneous Coronary Intervention in Acute Coronary Syndromes Treated With Fondaparinux:  The FUTURA/OASIS-8 Randomized Trial
The FUTURA/OASIS-8 Trial Group*
JAMA. 2010;304(12):1339-1349. doi:10.1001/jama.2010.1320.
INCLUDES: , Supplemental Content
JAMA Internal Medicine | 
Original Investigation |  September 13, 2010 FREE
A Population-Based Study of Inferior Vena Cava Filters in Patients With Acute Venous Thromboembolism
Frederick A. Spencer, MD; Shannon M. Bates, MD; Robert J. Goldberg, PhD; et al.
Arch Intern Med. 2010;170(16):1456-1462. doi:10.1001/archinternmed.2010.272.
INCLUDES: CME , Supplemental Content
JAMA Internal Medicine | 
Original Investigation |  September 13, 2010 FREE
Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation
Morten L. Hansen, MD, PhD; Rikke Sørensen, MD; Mette T. Clausen, MSc Pharm; et al.
Arch Intern Med. 2010;170(16):1433-1441. doi:10.1001/archinternmed.2010.271.
JAMA Neurology | 
Images in Neurology |  September 01, 2010
An Unusual Case of Chronic Dural Thrombosis
Fabio Pilato, MD; Simona Gaudino, MD; Paolo Profice, MD; et al.
Arch Neurol. 2010;67(9):1148-1149. doi:10.1001/archneurol.2010.212.
JAMA Neurology | 
Original Contribution |  September 01, 2010 FREE
Association of Admission Blood Glucose and Outcome in Patients Treated With Intravenous Thrombolysis:  Results From the Safe Implementation of Treatments in Stroke International Stroke Thrombolysis Register (SITS-ISTR)
Niaz Ahmed, MD, PhD; Antoni Dávalos, MD, PhD; Niclas Eriksson, Msc; et al.
Arch Neurol. 2010;67(9):1123-1130. doi:10.1001/archneurol.2010.210.
JAMA Neurology | 
Correspondence |  September 01, 2010
Will Symptomatic Intracerebral Hemorrhages Decrease Among Eligible Dabigatran-Treated Patients Who Receive Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke?
Lung Chan, MD, MSc
Arch Neurol. 2010;67(9):1156-1157. doi:10.1001/archneurol.2010.205.
JAMA Neurology | 
Correspondence |  September 01, 2010
Will Symptomatic Intracerebral Hemorrhages Decrease Among Eligible Dabigatran-Treated Patients Who Receive Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke?—Reply
Shyam Prabhakaran, MD, MS
Arch Neurol. 2010;67(9):1156-1157. doi:10.1001/archneurol.2010.206.
JAMA | 
Medical News & Perspectives |  August 25, 2010
FDA Approves Generic Enoxaparin
Rebecca Voelker
JAMA. 2010;304(8):844. doi:10.1001/jama.2010.1195.
JAMA Internal Medicine | 
Original Investigation |  August 09, 2010 FREE
Simplification of the Pulmonary Embolism Severity Index for Prognostication in Patients With Acute Symptomatic Pulmonary Embolism
David Jiménez, MD, PhD; Drahomir Aujesky, MD; Lisa Moores, MD; et al.
Arch Intern Med. 2010;170(15):1383-1389. doi:10.1001/archinternmed.2010.199.
INCLUDES: CME
JAMA Internal Medicine | 
Original Investigation |  August 09, 2010 FREE
Outcomes and Processes of Care Related to Preoperative Medical Consultation
Duminda N. Wijeysundera, MD; Peter C. Austin, PhD; W. Scott Beattie, MD, PhD; et al.
Arch Intern Med. 2010;170(15):1365-1374. doi:10.1001/archinternmed.2010.204.
INCLUDES: , Supplemental Content
JAMA Neurology | 
Original Contribution |  August 01, 2010 FREE
Management of Thrombolysis-Associated Symptomatic Intracerebral Hemorrhage
Joshua N. Goldstein, MD, PhD; Marisela Marrero, MD; Shihab Masrur, MD; et al.
Arch Neurol. 2010;67(8):965-969. doi:10.1001/archneurol.2010.175.
JAMA Dermatology | 
Correspondence |  August 01, 2010
Livedoid Vasculopathy in a Pediatric Patient With Elevated Lipoprotein(a) Levels: Prompt Response to Continuous Low-Molecular-Weight Heparin
Tobias Goerge, MD; Carsten Weishaupt, MD; Dieter Metze, MD; et al.
Arch Dermatol. 2010;146(8):918-935. doi:10.1001/archdermatol.2010.177.
JAMA | 
The Rational Clinical Examination |  July 07, 2010
Can This Patient Read and Understand Written Health Information?
Benjamin J. Powers, MD, MHS; Jane V. Trinh, MD; Hayden B. Bosworth, PhD
JAMA. 2010;304(1):76-84. doi:10.1001/jama.2010.896.
INCLUDES: CME , Supplemental Content

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Original Investigation  |  April 1, 2013
Use of Glucocorticoids and Risk of Venous Thromboembolism:  A Nationwide Population-Based Case-Control Study
Sigrun A. Johannesdottir, BSc; Erzsébet Horváth-Puhó, MSc, PhD; Olaf M. Dekkers, MD, PhD, MSc, MA; et al.
JAMA Internal Medicine
In This Issue of JAMA Internal Medicine  |  May 13, 2013
In This Issue of JAMA Internal Medicine
JAMA Internal Medicine
Editor's Correspondence  |  May 13, 2013
Resumption of Warfarin Therapy After Gastrointestinal Tract Bleeding: Benefit or Bias?
Kristian B. Filion, PhD; Jonathan Assayag, MSc; Laurent Azoulay, PhD
JAMA Internal Medicine
Editor's Correspondence  |  May 13, 2013
Resumption of Warfarin Therapy After Gastrointestinal Tract Bleeding: Benefit or Bias?—Reply
Daniel M. Witt, PharmD; Thomas Delate, PhD; Mark A. Crowther, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems